Bone Marrow Transplantation - Table of Contents alert Volume 52 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 52, Issue 2 (February 2017) In this issue Obituary Reviews Special Report Commentaries Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Obituary Top Professor David Grimwade (1962–2016) N H Russell, S D Freeman and C Craddock Bone Marrow Transplant 2017 52: 171-172; advance online publication, January 16, 2017; 10.1038/bmt.2016.350 Full Text Reviews Top Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT Z DeFilipp, R F Duarte, J A Snowden, N S Majhail, D M Greenfield, J L Miranda, M Arat, K S Baker, L J Burns, C N Duncan, M Gilleece, G A Hale, M Hamadani, B K Hamilton, W J Hogan, J W Hsu, Y Inamoto, R T Kamble, M T Lupo-Stanghellini, A K Malone, P McCarthy, M Mohty, M Norkin, P Paplham, M Ramanathan, J M Richart, N Salooja, H C Schouten, H Schoemans, A Seber, A Steinberg, B M Wirk, W A Wood, M Battiwalla, M E D Flowers, B N Savani and B E Shaw on behalf of the CIBMTR Late Effects and Quality of Life Working Committee and the EBMT Complications and Quality of Life Working Party Bone Marrow Transplant 2017 52: 173-182; advance online publication, August 22, 2016; 10.1038/bmt.2016.203 Abstract | Full Text Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation J Whangbo, J Ritz and A Bhatt Bone Marrow Transplant 2017 52: 183-190; advance online publication, August 15, 2016; 10.1038/bmt.2016.206 Abstract | Full Text Special Report Top Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT) J R Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, R F Duarte, C Dufour, J Kuball, D Farge-Bancel, A Gennery, N Kröger, F Lanza, A Nagler, A Sureda and M Mohty for the European Society for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplant 2017 52: 191-196; advance online publication, November 7, 2016; 10.1038/bmt.2016.258 Abstract | Full Text Commentaries Top Therapy of pediatric ALL relapsing after allogeneic transplant: how to make progress with limited patient numbers? M Bierings Bone Marrow Transplant 2017 52: 197-198; advance online publication, November 28, 2016; 10.1038/bmt.2016.276 Full Text Diffuse large B-cell lymphoma: the challenge of relapse after an autologous stem cell transplant S P Robinson Bone Marrow Transplant 2017 52: 199-200; advance online publication, November 21, 2016; 10.1038/bmt.2016.292 Full Text Original Articles Top ACUTE LEUKEMIA Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience A M Willasch, E Salzmann-Manrique, T Krenn, M Duerken, J Faber, J Opper, H Kreyenberg, R Bager, S Huenecke, C Cappel, M Bremm, V Pfirrmann, M Merker, E Ullrich, S Bakhtiar, E Rettinger, A Jarisch, J Soerensen, T E Klingebiel and P Bader Bone Marrow Transplant 2017 52: 201-208; advance online publication, September 19, 2016; 10.1038/bmt.2016.224 Abstract | Full Text Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT M Robin, R Porcher, W Zinke-Cerwenka, A van Biezen, L Volin, G Mufti, C Craddock, J Finke, C Richard, J Passweg, A Peniket, J Maertens, G Sucak, T Gedde-Dahl, A Vitek, A Nagler, D Blaise, D Beelen, N Maillard, R Schwerdtfeger, T de Witte and N Kroger Bone Marrow Transplant 2017 52: 209-215; advance online publication, November 7, 2016; 10.1038/bmt.2016.266 Abstract | Full Text LYMPHOMA Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study E Van Den Neste, N Schmitz, N Mounier, D Gill, D Linch, M Trneny, R Bouadballah, J Radford, M Bargetzi, V Ribrag, U Dührsen, D Ma, J Briere, C Thieblemont, E Bachy, C H Moskowitz, B Glass and C Gisselbrecht Bone Marrow Transplant 2017 52: 216-221; advance online publication, September 19, 2016; 10.1038/bmt.2016.213 Abstract | Full Text PLASMA CELL DISORDERS Peripheral blood stem cell mobilization in multiple myeloma comparison of two consecutive regimens in a limited resources country N Ben Abdejlil, D Belloumi, M Mâammar, R El Fatimi, L Torjman, A Lakhal, F Jenhani, S Hmida, T Ben Othman and S Ladeb Bone Marrow Transplant 2017 52: 222-227; advance online publication, October 24, 2016; 10.1038/bmt.2016.246 Abstract | Full Text Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients R Oostvogels, E Kneppers, M C Minnema, R C Doorn, L E Franssen, T Aarts, M E Emmelot, E Spierings, I Slaper-Cortenbach, K Westinga, E Goulmy, H M Lokhorst and T Mutis Bone Marrow Transplant 2017 52: 228-237; advance online publication, November 14, 2016; 10.1038/bmt.2016.250 Abstract | Full Text CONDITIONING Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT S Eder, M Labopin, J Finke, D Bunjes, A Olivieri, S Santarone, A Rambaldi, L Kanz, G Messina, M Mohty and A Nagler on behalf of the ALWP of the EBMT Bone Marrow Transplant 2017 52: 238-244; advance online publication, September 19, 2016; 10.1038/bmt.2016.239 Abstract | Full Text TRANSPLANT TOXICITIES Thrombomodulin blocks calcineurin inhibitor-induced vascular permeability via inhibition of Src/VE-cadherin axis T Ikezoe, J Yang, C Nishioka, K Umezawa and A Yokoyama Bone Marrow Transplant 2017 52: 245-251; advance online publication, September 19, 2016; 10.1038/bmt.2016.241 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT M Murata, K Ikegame, Y Morishita, H Ogawa, K Kaida, H Nakamae, T Ikeda, T Nishida, M Inoue, T Eto, K Kubo, T Sakura, T Mori, N Uchida, T Ashida, Y Matsuhashi, Y Miyazaki, T Ichinohe, Y Atsuta and T Teshima Bone Marrow Transplant 2017 52: 252-257; advance online publication, November 21, 2016; 10.1038/bmt.2016.247 Abstract | Full Text DONOR SAFETY Predictors of general discomfort, limitations in activities of daily living and intention of a second donation in unrelated hematopoietic stem cell donation M H Lee, J H Jang, H J Min, H I Jang, J H Nah, C J Lyu, K-S Han, J H Won, Y-H Lee, S Y Chong, Y C Mun, W S Lee, S J Kim and I Kim Bone Marrow Transplant 2017 52: 258-263; advance online publication, November 7, 2016; 10.1038/bmt.2016.260 Abstract | Full Text INFECTIONS Association of Epstein–Barr virus reactivation with the recovery of CD4/CD8 double-negative T lymphocytes after haploidentical hematopoietic stem cell transplantation Z Bian, J Liu, L-P Xu, Y-J Chang, Y Wang, X-H Zhang and X-J Huang Bone Marrow Transplant 2017 52: 264-269; advance online publication, October 31, 2016; 10.1038/bmt.2016.238 Abstract | Full Text Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study R T Maziarz, R Brazauskas, M Chen, A A McLeod, R Martino, J R Wingard, M Aljurf, M Battiwalla, C C Dvorak, B Geroge, E C Guinan, G A Hale, H M Lazarus, J-W Lee, J L Liesveld, M Ramanathan, V Reddy, B N Savani, F O Smith, L Strasfeld, R A Taplitz, C Ustun, M J Boeckh, J Gea-Banacloche, C A Lindemans, J J Auletta and M L Riches Bone Marrow Transplant 2017 52: 270-278; advance online publication, December 19, 2016; 10.1038/bmt.2016.259 Abstract | Full Text QOL AND PATIENTS' CARE Cognitive problems following hematopoietic stem cell transplant: relationships with sleep, depression and fatigue S E Ghazikhanian, C S Dorfman, T J Somers, M L O'Sullivan, H M Fisher, S N Edmond, A A Wren, S A Kelleher, K A Rowe Nichols, N Chao and R A Shelby Bone Marrow Transplant 2017 52: 279-284; advance online publication, December 12, 2016; 10.1038/bmt.2016.248 Abstract | Full Text Preliminary efficacy of a brief family intervention to prevent declining quality of life secondary to parental bone marrow transplantation B L Fife, D M Von Ah, M L Spath, M T Weaver, Z Yang, T Stump and S Farag Bone Marrow Transplant 2017 52: 285-291; advance online publication, November 21, 2016; 10.1038/bmt.2016.267 Abstract | Full Text CLINICAL TRIAL DESIGN A qualitative exploration of the informed consent process in hematopoietic cell transplantation clinical research and opportunities for improvement M Raj, S W Choi and J Platt Bone Marrow Transplant 2017 52: 292-298; advance online publication, October 17, 2016; 10.1038/bmt.2016.252 Abstract | Full Text Letters to the Editor Top Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant OPEN S Issaragrisil, T Cheng-Hwai, U Bunworasate, Y Su-Peng, L Y Hung, G Y Tee, S F A Wahid, N S Chin, T Puavilai, G G Gin, K L Piu, H Wen-Li, C Tsai-Yun and T Numbenjapon Bone Marrow Transplant 2017 52: 299-300; advance online publication, November 14, 2016; 10.1038/bmt.2016.245 Full Text Low day +100 serum epidermal growth factor levels are associated with acute GvHD after allogeneic hematopoietic cell transplantation F He, M R Verneris, S Cooley, B R Blazar, M L MacMillan, L F Newell, A Panoskaltsis-Mortari, T DeFor, D J Weisdorf and S G Holtan Bone Marrow Transplant 2017 52: 301-303; advance online publication, November 21, 2016; 10.1038/bmt.2016.261 Full Text Medication nonadherence to immunosuppressants after adult allogeneic haematopoietic stem cell transplantation: a multicentre cross-sectional study B Gresch, M Kirsch, K Fierz, J P Halter, G Nair, K Denhaerynck and S De Geest Bone Marrow Transplant 2017 52: 304-306; advance online publication, November 14, 2016; 10.1038/bmt.2016.262 Full Text Danaparoid reduces the incidence of hematopoietic stem cell transplantation-associated thrombotic microangiopathy S Machida, M Onizuka, M Toyosaki, Y Aoyama, H Kawai, J Amaki, R Hara, A Ichiki, Y Ogawa, H Kawada and K Ando Bone Marrow Transplant 2017 52: 307-309; advance online publication, November 28, 2016; 10.1038/bmt.2016.270 Full Text First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin’s lymphoma D Ghez, C Fortpied, N Mounier, P Carde, A Perrot, H Khaled, S Amorim, S Ramadan, F L Bras, M Erlanson, C Herbaux, J-P Marolleau, E Nicolas-Virelezier, O Casasnovas, A Stamatoullas-Bastard and C Fermé on behalf of EORTC, LYSA, LYMG and NLG cooperating groups Bone Marrow Transplant 2017 52: 310-312; advance online publication, November 28, 2016; 10.1038/bmt.2016.271 Full Text Anti-Muellerian hormone (AMH) as only possible marker in the assessment of ovarian function and reserve after hematopoietic stem cell transplantation (HSCT) in prepubertal girls, young females with composed hypogonadism and females receiving hormonal replacement therapy A Wędrychowicz, J Wojtyś and J Starzyk Bone Marrow Transplant 2017 52: 313-316; advance online publication, November 14, 2016; 10.1038/bmt.2016.273 Full Text PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation J C Albring, S Inselmann, T Sauer, C Schliemann, B Altvater, S Kailayangiri, C Rössig, W Hartmann, J R Knorrenschild, K Sohlbach, C Groth, M Lohoff, A Neubauer, W E Berdel, A Burchert and M Stelljes Bone Marrow Transplant 2017 52: 317-320; advance online publication, November 28, 2016; 10.1038/bmt.2016.274 Full Text Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL) N Shah, S Rauenzahn, L Veltri, S Wen, M Craig, M Hamadani, A S Kanate and A Cumpston Bone Marrow Transplant 2017 52: 321-322; advance online publication, November 28, 2016; 10.1038/bmt.2016.275 Full Text Prior history of HLA-mismatched stem cell transplantation is a risk factor for graft failure in HLA-haploidentical transplantation J Sugita, T Miyamoto, N Kawashima, N Hatsumi, N Anzai, H Kaneko, M Nara, K Minauchi, M Harada and T Teshima on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT) Bone Marrow Transplant 2017 52: 323-325; advance online publication, November 7, 2016; 10.1038/bmt.2016.278 Full Text Serum galactomannan surveillance may be safely withdrawn from antifungal management of hematology patients on effective antimold prophylaxis: a pilot single-center study R F Duarte, I Sánchez-Ortega, M Arnan, B Patiño, J Ayats, A Sureda and M Cuenca-Estrella Bone Marrow Transplant 2017 52: 326-329; advance online publication, October 31, 2016; 10.1038/bmt.2016.279 Full Text Successful haploidentical stem cell transplantation for three adults with primary hemophagocytic lymphohistiocytosis Z Li, Y Wang, J Wang, J Zhang and Z Wang Bone Marrow Transplant 2017 52: 330-333; advance online publication, October 24, 2016; 10.1038/bmt.2016.284 Full Text Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse F Gössi, M Spahn, M Zweifel, S Panagiotis, A Mischo, F Stenner, U Hess, D Berthold, M Bargetzi, J Schardt and T Pabst Bone Marrow Transplant 2017 52: 334-336; advance online publication, November 28, 2016; 10.1038/bmt.2016.285 Full Text A proposed biology- and biomarker-based algorithm for management of acute GvHD A M Ali, J F DiPersio and M A Schroeder Bone Marrow Transplant 2017 52: 337-340; advance online publication, November 21, 2016; 10.1038/bmt.2016.289 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.